scholarly article | Q13442814 |
P356 | DOI | 10.1016/0140-6736(92)91057-F |
P698 | PubMed publication ID | 1346819 |
P2093 | author name string | P. Smith | |
M. Abdelnoor | |||
H. Arnesen | |||
F. Wisløff | |||
K. E. Sletnes | |||
P433 | issue | 8791 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
P304 | page(s) | 451-453 | |
P577 | publication date | 1992-02-01 | |
1992-02-22 | |||
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke | |
P478 | volume | 339 |
Q37790448 | A review of hereditary and acquired coagulation disorders in the aetiology of ischaemic stroke |
Q44234343 | Annexin V levels in survivors of early myocardial infarction |
Q41673431 | Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease |
Q71691168 | Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study |
Q55365972 | Anticardiolipin antibodies and cardiovascular disease. |
Q33612761 | Anticardiolipin antibodies in ischaemic heart disease: marker or myth? |
Q71482152 | Antiphospholipid antibodies in heart transplant recipients |
Q40583128 | Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: a unifying 'membrane stress syndrome' hypothesis |
Q34331685 | Antiphospholipid syndrome; its implication in cardiovascular diseases: a review |
Q33890407 | Autoantibodies to modified LDLs and other phospholipid-protein complexes as markers of cardiovascular diseases |
Q36283448 | Cardiac involvement in the antiphospholipid syndrome |
Q61914430 | Chapter 8 Systemic Manifestations of the Antiphospholipid Syndrome |
Q40529762 | Clinical and therapeutic aspects of the antiphospholipid syndrome |
Q33490045 | Clinical trials on antiphospholipid syndrome: what is being done and what is needed? |
Q40519206 | Clinicopathologic correlations of the antiphospholipid syndrome |
Q40887411 | Heterogeneity of autoantibodies against cardiolipin and oxidatively modified LDLs revealed by human monoclonal antibodies |
Q26750752 | Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis |
Q33492572 | Importance of serum anticardiolipin antibody levels in coronary heart disease |
Q37244413 | Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction |
Q61943926 | LUPUS ANTICOAGULANTS AND ANTIPHOSPHOLIPID ANTIBODIES |
Q58854434 | Lymphomes malins et syndrome des antiphospholipides non simultanés : quatre observations |
Q71112355 | Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry |
Q35008513 | Phospholipid autoantibodies: time for a new immuno-assay? |
Q37775992 | Screening for coagulation disorders in patients with ischemic stroke |
Q35189292 | Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. |
Q34151618 | The clinical significance of antiphospholipid antibodies in patients without autoimmune disease |
Q37959884 | The management of stroke in antiphospholipid syndrome |
Q35683321 | The role of endothelial cell reactive antibodies in peripheral vascular disease |
Q35610110 | Thrombophilia and stroke |
Q74521081 | [Pathology of diseases of extracardiac origin. VI. Disease of the connective tissue and heart] |
Q73960298 | [Prevalence of antiphospholipid syndrome in patients under 65 years of age with acute myocardial infarction] |
Search more.